MV-130 is under clinical development by Inmunotek and currently in Phase II for Lower Respiratory Tract Infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback